» CRYOcheck™ Prekallikrein Deficient Plasma

HEMOSTASIS COAGULATION ROUTINE FROZEN IMMUNODEPLETED DEFICIENT PLASMAS INTRINSIC PATHWAY PREKALLIKREIN

CRYOcheck™ Prekallikrein Deficient Plasma

Fresh frozen plasmas

Plasma deficient for the determination of prekallikrein.

CRYOcheck™Prekallikrein Deficient is a congenital frozen plasma, low in platelets and certified to have less than 1% prekallikrein

Access publications on the manufacturer's website

Reference	FDPK-10
Presentation	Kit
Format	10 x 1.0 mL
Number of assays	200
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Number of assays	Quote	Product sheet
FDPK-10	Kit	10 x 1.0 mL	200

Price list, safety data sheets and notices are accessible to our registered customers.

CRYOcheck™ Prekallikrein Deficient Plasma Certificate of analysis

Prekallikrein is a glycoprotein, a serine protease zymogen. Non-covalently complexed with high molecular weight kininogen.
Prekallikrein participates in the activation of coagulation, fibrinolysis, the generation of kinins and inflammatory phenomena.
It is activated into kallikrein by FXIIa.

CRYOcheck ™ Factor Deficient Plasma are made from citrated human plasma pools with congenital prekallikrein deficiency, buffered with HEPES buffer, aliquoted and quickly frozen.

- Certificate of analysis supplied with each batch.
- The other factors have been tested and the results are provided on the Certificate of Analysis that accompanies each lot number.
- Expiration date of 3 years from the date of manufacture with storage between -40 °C and -80 °C

- CE adaptation on many analyzers on the market
- Technical validation file
- Reserved lots
- Ready to use

- 10 cryotubes x 1 mL

CRYOcheck™ Abnormal 1 Reference Control
CRYOcheck™ Abnormal 2 Reference Control
CRYOcheck™ Normal Reference Plasma
CRYOcheck™ Reference Control Normal

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE FROZEN IMMUNODEPLETED DEFICIENT PLASMAS INTRINSIC PATHWAY PREKALLIKREIN